Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Posner

Showing results (211-220 of 247) with videos related to

Pageof 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trialA D Colevas, P M Busse, C M Norris, et al.
Journal of Human Virology|July 5, 2001
Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade BW Xu, B A Smith-Franklin, P L Li, et al.
Carcinogenesis|January 8, 2009
Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinomaCarmen J Marsit, Brock C Christensen, E Andres Houseman, et al.
AIDS Research and Human Retroviruses|July 20, 1996
In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160S H Pincus, K Wehrly, R Cole, et al.
Cancer Research|October 17, 2014
Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancerFalguni Parikh, Dorothée Duluc, Naoko Imai, et al.
The Oncologist|August 12, 2016
Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled TrialWeidong Lu, Peter M Wayne, Roger B Davis, et al.
Oral Oncology|July 27, 2019
Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trialK Misiukiewicz, V Gupta, B A Miles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitorRobert I Haddad, Lisa J Weinstein, Tad J Wieczorek, et al.
Oral Oncology|March 30, 2017
Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatmentYuehan Zhang, Tim Waterboer, Robert I Haddad, et al.
The Oncologist|March 6, 2021
De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) TrialBrett A Miles, Marshall R Posner, Vishal Gupta, et al.
Pageof 25

Showing results (211-220 of 247) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trialA D Colevas, P M Busse, C M Norris, et al.
Journal of Human Virology|July 5, 2001
Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade BW Xu, B A Smith-Franklin, P L Li, et al.
Carcinogenesis|January 8, 2009
Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinomaCarmen J Marsit, Brock C Christensen, E Andres Houseman, et al.
AIDS Research and Human Retroviruses|July 20, 1996
In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160S H Pincus, K Wehrly, R Cole, et al.
Cancer Research|October 17, 2014
Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancerFalguni Parikh, Dorothée Duluc, Naoko Imai, et al.
The Oncologist|August 12, 2016
Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled TrialWeidong Lu, Peter M Wayne, Roger B Davis, et al.
Oral Oncology|July 27, 2019
Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trialK Misiukiewicz, V Gupta, B A Miles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitorRobert I Haddad, Lisa J Weinstein, Tad J Wieczorek, et al.
Oral Oncology|March 30, 2017
Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatmentYuehan Zhang, Tim Waterboer, Robert I Haddad, et al.
The Oncologist|March 6, 2021
De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) TrialBrett A Miles, Marshall R Posner, Vishal Gupta, et al.
Pageof 25